• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NanoString nCounter FusionPlex 分析在软组织肿瘤中的诊断产量。

Diagnostic yield of NanoString nCounter FusionPlex profiling in soft tissue tumors.

机构信息

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Genes Chromosomes Cancer. 2020 May;59(5):318-324. doi: 10.1002/gcc.22834. Epub 2020 Jan 31.

DOI:10.1002/gcc.22834
PMID:31965673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7079105/
Abstract

Diagnostic histopathology of soft tissue tumors can be troublesome as many entities are quite rare and have overlapping morphologic features. Many soft tissue tumors harbor tumor-defining gene translocations, which may provide an important ancillary tool for tumor diagnosis. The NanoString nCounter platform enables multiplex detection of pre-defined gene fusion transcripts in formalin-fixed and paraffin-embedded tissue. A cohort of 104 soft tissue tumors representing 20 different histological types was analyzed for the expression of 174 unique gene fusion transcripts. A tumor-defining gene fusion transcript was detected in 60 cases (58%). Sensitivity and specificity of the NanoString assay calculated against the result of an alternative molecular method were 85% and 100%, respectively. Highest diagnostic coverage was obtained for Ewing sarcoma, synovial sarcoma, myxoid liposarcoma, alveolar rhabdomyosarcoma, and desmoplastic small round cell tumor. For these tumor types, the NanoString assay is a rapid, cost-effective, sensitive, and specific ancillary screening tool for molecular diagnosis. For other sarcomas, additional molecular testing may be required when a translocation transcript is not identified with the current 174 gene fusion panel.

摘要

软组织肿瘤的诊断组织病理学可能会很麻烦,因为许多实体瘤非常罕见,并且具有重叠的形态学特征。许多软组织肿瘤存在肿瘤定义基因易位,这可能为肿瘤诊断提供重要的辅助工具。 NanoString nCounter 平台可用于检测福尔马林固定和石蜡包埋组织中预先定义的基因融合转录本的多重检测。对代表 20 种不同组织学类型的 104 种软组织肿瘤进行了分析,以检测 174 种独特的基因融合转录本。在针对替代分子方法的结果计算时,NanoString 检测法的敏感性和特异性分别为 85%和 100%。Ewing 肉瘤、滑膜肉瘤、黏液样脂肪肉瘤、腺泡状横纹肌肉瘤和促结缔组织增生性小圆细胞肿瘤的诊断覆盖率最高。对于这些肿瘤类型,NanoString 检测法是一种快速、具有成本效益、敏感且特异性的辅助分子诊断筛选工具。对于其他肉瘤,当当前的 174 个基因融合面板未识别出易位转录本时,可能需要进行其他分子检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46f6/7079105/87f76aafc209/GCC-59-318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46f6/7079105/04eefc53937e/GCC-59-318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46f6/7079105/87f76aafc209/GCC-59-318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46f6/7079105/04eefc53937e/GCC-59-318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46f6/7079105/87f76aafc209/GCC-59-318-g002.jpg

相似文献

1
Diagnostic yield of NanoString nCounter FusionPlex profiling in soft tissue tumors.NanoString nCounter FusionPlex 分析在软组织肿瘤中的诊断产量。
Genes Chromosomes Cancer. 2020 May;59(5):318-324. doi: 10.1002/gcc.22834. Epub 2020 Jan 31.
2
Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.利用存档石蜡包埋组织通过巢式逆转录聚合酶链反应检测黏液样和圆形细胞脂肪肉瘤中的 TLS/FUS-CHOP 融合转录本
Diagn Mol Pathol. 1998 Apr;7(2):96-101. doi: 10.1097/00019606-199804000-00006.
3
Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.EWS/Fli1易位各种外显子组合的鉴定:一种针对石蜡包埋组织的优化逆转录聚合酶链反应方法——CWS研究小组的报告
Klin Padiatr. 2004 Nov-Dec;216(6):315-22. doi: 10.1055/s-2004-832338.
4
Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study.分子遗传学检测在肉瘤外科病理诊断中的实际应用:一项前瞻性研究。
Am J Surg Pathol. 2002 Aug;26(8):965-77. doi: 10.1097/00000478-200208000-00001.
5
Detection of fusion gene transcripts in fresh-frozen and formalin-fixed paraffin-embedded tissue sections of soft-tissue sarcomas after laser capture microdissection and rt-PCR.激光捕获显微切割和逆转录聚合酶链反应后软组织肉瘤新鲜冷冻及福尔马林固定石蜡包埋组织切片中融合基因转录本的检测
Diagn Mol Pathol. 2003 Dec;12(4):224-30. doi: 10.1097/00019606-200312000-00006.
6
Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor.逆转录聚合酶链反应在肺泡横纹肌肉瘤、尤因肉瘤家族性肿瘤及促纤维增生性小圆细胞肿瘤诊断与分期中的应用
J Pediatr Hematol Oncol. 2001 Feb;23(2):99-104. doi: 10.1097/00043426-200102000-00006.
7
Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter Platform.基于 NanoString nCounter 平台的泛肉瘤融合基因检测试剂盒的开发与评估。
J Mol Diagn. 2018 Jan;20(1):63-77. doi: 10.1016/j.jmoldx.2017.09.007. Epub 2017 Nov 20.
8
Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue.一种用于检测存档组织中肿瘤特异性融合转录本的逆转录聚合酶链反应检测法的性能特征
Pediatr Dev Pathol. 2003 Jan-Feb;6(1):43-53. doi: 10.1007/s10024-002-0013-1. Epub 2002 Oct 14.
9
Mesenchymal Tumors with EWSR1 Gene Rearrangements.伴有EWSR1基因重排的间叶性肿瘤
Surg Pathol Clin. 2019 Mar;12(1):165-190. doi: 10.1016/j.path.2018.10.007.
10
Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.定义尤因肉瘤及尤因肉瘤样小圆细胞肿瘤(SRCT):分子技术在其分类及鉴别诊断中的必要性。一项200例病例的研究
Ann Diagn Pathol. 2016 Jun;22:25-32. doi: 10.1016/j.anndiagpath.2016.03.002. Epub 2016 Mar 14.

引用本文的文献

1
Brain-associated alterations of Hippo pathway transcription in early maturing Atlantic salmon.早熟大西洋鲑鱼中与大脑相关的Hippo信号通路转录变化
BMC Ecol Evol. 2025 May 26;25(1):53. doi: 10.1186/s12862-025-02398-4.
2
Enhancing precision in sarcoma diagnosis: nCounter fusion panel implementation in a middle-income country.提高肉瘤诊断的精准度:在中等收入国家实施nCounter融合检测平台
Ther Adv Med Oncol. 2025 Mar 14;17:17588359251318159. doi: 10.1177/17588359251318159. eCollection 2025.
3
Rapid gene fusion testing using the NanoString nCounter platform to improve pediatric leukemia diagnoses in Sub-Saharan Africa.

本文引用的文献

1
Diagnostic classification of soft tissue malignancies: A review and update from a surgical pathology perspective.软组织恶性肿瘤的诊断分类:外科病理学视角的回顾与更新。
Curr Probl Cancer. 2019 Aug;43(4):250-272. doi: 10.1016/j.currproblcancer.2019.05.006. Epub 2019 May 28.
2
Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.用于改善髓母细胞瘤预后预测的NanoString 22基因分子亚组分析的可重复性
Neuropathology. 2018 Oct;38(5):475-483. doi: 10.1111/neup.12508. Epub 2018 Aug 28.
3
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing.
使用NanoString nCounter平台进行快速基因融合检测,以改善撒哈拉以南非洲地区儿童白血病的诊断。
Front Oncol. 2024 Jun 13;14:1426638. doi: 10.3389/fonc.2024.1426638. eCollection 2024.
4
Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.基于 RNA 的 nCounter 检测 NTRK 融合可作为一种可行的诊断方法,用于评估非小细胞肺癌的实际情况。
Sci Rep. 2023 Dec 1;13(1):21168. doi: 10.1038/s41598-023-48613-4.
5
Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing.使用低成本纳米孔 mRNA 测序的转录谱进行急性白血病分类。
JCO Precis Oncol. 2022 Apr;6:e2100326. doi: 10.1200/PO.21.00326.
6
Rhabdomyosarcoma in Adults: Case Series and Literature Review.成人横纹肌肉瘤:病例系列与文献综述
Int J Womens Health. 2022 Mar 28;14:405-414. doi: 10.2147/IJWH.S352143. eCollection 2022.
7
Current Status of Management and Outcome for Patients with Ewing Sarcoma.尤因肉瘤患者的治疗现状与预后
Cancers (Basel). 2021 Mar 10;13(6):1202. doi: 10.3390/cancers13061202.
8
RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients.基于RNA的多重检测法用于非小细胞肺癌患者细胞学样本中融合和剪接变体的常规检测
Diagnostics (Basel). 2020 Dec 23;11(1):15. doi: 10.3390/diagnostics11010015.
9
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape.突破技术重塑尤文肉瘤分子图谱。
Cells. 2020 Mar 26;9(4):804. doi: 10.3390/cells9040804.
基于锚定多重 PCR 的靶向下一代测序技术对骨和软组织肿瘤中基因融合的分子分析。
J Mol Diagn. 2018 Sep;20(5):653-663. doi: 10.1016/j.jmoldx.2018.05.007. Epub 2018 Aug 20.
4
Sarcoma Subgrouping by Detection of Fusion Transcripts Using NanoString nCounter Technology.使用NanoString nCounter技术通过检测融合转录本来进行肉瘤亚组分类。
Pediatr Dev Pathol. 2019 May-Jun;22(3):205-213. doi: 10.1177/1093526618790747. Epub 2018 Aug 8.
5
Transcriptomic definition of molecular subgroups of small round cell sarcomas.转录组学定义小圆细胞肉瘤的分子亚群。
J Pathol. 2018 May;245(1):29-40. doi: 10.1002/path.5053. Epub 2018 Mar 30.
6
Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study.基于新一代测序靶向基因panel 在常规实践中进行癌症诊断的费用:一项全国性的法国研究。
Eur J Hum Genet. 2018 Mar;26(3):314-323. doi: 10.1038/s41431-017-0081-3. Epub 2018 Jan 24.
7
Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter Platform.基于 NanoString nCounter 平台的泛肉瘤融合基因检测试剂盒的开发与评估。
J Mol Diagn. 2018 Jan;20(1):63-77. doi: 10.1016/j.jmoldx.2017.09.007. Epub 2017 Nov 20.
8
Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.伴有CIC重排的肉瘤是一种具有侵袭性预后的独特病理实体:115例病例的临床病理和分子研究
Am J Surg Pathol. 2017 Jul;41(7):941-949. doi: 10.1097/PAS.0000000000000846.
9
NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics.NanoString,一种新型的数字彩色条码技术:在分子诊断学中的当前和未来应用。
Expert Rev Mol Diagn. 2017 Jan;17(1):95-103. doi: 10.1080/14737159.2017.1268533. Epub 2016 Dec 12.
10
Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples.评估 NanoString Technologies nCounter 平台的稳健性和灵敏度,以实现临床样本的多重基因表达分析。
Cancer Res. 2015 Jul 1;75(13):2587-93. doi: 10.1158/0008-5472.CAN-15-0262. Epub 2015 Jun 11.